Why the study?
Coronary microvascular dysfunction is an important and often underrecognized contributor to ischemic symptoms and cardiovascular risk in women, with distinct features from ischemic heart disease in men.
Highlights the growing body of evidence supporting coronary microvascular dysfunction as an important contributor to ischemic symptoms and cardiovascular risk in women.
May prompt CMD evaluation in women with ischemic symptoms; leaves open optimal diagnostic and therapeutic strategies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Alexandre et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: